Nerve-sparing radical prostatectomy using the neurovascular structure-adjacent frozen-section examination (NeuroSAFE): results after 20 years of experience
- PMID: 38862777
- DOI: 10.1038/s41391-024-00851-x
Nerve-sparing radical prostatectomy using the neurovascular structure-adjacent frozen-section examination (NeuroSAFE): results after 20 years of experience
Abstract
Objectives: To evaluate the long-term oncological outcomes and functional results of the neurovascular structure-adjacent frozen-section examination (NeuroSAFE) during nerve-sparing (NS) radical prostatectomy (RP).
Materials and methods: A 10-yr survival analysis on 11069 RPs performed with or without the NeuroSAFE, between January 2002 to June 2011 was carried out. In the NeuroSAFE cohort, the neurovascular structure-adjacent prostatic margins are removed and stained for cryo-sectioning during RP. In case of a PSM, partial or full removal of the neurovascular bundle was performed. The impact of NeuroSAFE on biochemical recurrence-free survival (BFS), salvage radiation therapy-free survival, metastasis-free survival, and prostate cancer-specific survival at 10 years was analyzed. 1-year (1-yr) erectile function (EF), 1-yr, and 2-yr continence rates were assessed in propensity score-based matched cohorts.
Results: Median follow-up was 121 (IQR: 73, 156) months. No differences in BFS between NeuroSAFE and non-NeuroSAFE were recorded (10-yr BFS: NeuroSAFE vs non-Neurosafe, pT2: 81% vs 84%, p = 0.06; pT3a: 58% vs. 63%, p = 0.6; ≥pT3b: 22% vs. 27%, p = 0.99). No differences were found between the two groups in terms of sRFS (pT2: p = 0.1; pT3a: p = 0.4; ≥pT3b: p = 0.4) (Fig. 1B, Table 2), and MTS (pT2: p = 0.3; pT3a: p = 0.6; ≥pT3b: p = 0.9). The NeuroSAFE-navigated patients reported a better 1-yr EF than non-NeuroSAFE (68% vs. 58%, p = 0.02) and no differences in 1-yr and 2-yr continence rates (92.4% vs. 91.8%, and 93.4% vs. 93%, respectively). The main limitation is the retrospective study design.
Conclusions: While the NeuroSAFE approach did not show significant improvements in long-term oncologic or continence outcomes, it did provide an opportunity for a higher proportion of patients to improve postoperative functional results, possibly through increased nerve-sparing procedures.
© 2024. The Author(s), under exclusive licence to Springer Nature Limited.
Conflict of interest statement
Competing interests: The authors declare no competing interests.
Similar articles
-
Neurovascular structure-adjacent frozen-section examination (NeuroSAFE) increases nerve-sparing frequency and reduces positive surgical margins in open and robot-assisted laparoscopic radical prostatectomy: experience after 11,069 consecutive patients.Eur Urol. 2012 Aug;62(2):333-40. doi: 10.1016/j.eururo.2012.04.057. Epub 2012 May 10. Eur Urol. 2012. PMID: 22591631
-
The neurovascular structure-adjacent frozen-section examination (NeuroSAFE) approach to nerve sparing in robot-assisted laparoscopic radical prostatectomy in a British setting - a prospective observational comparative study.BJU Int. 2018 Jun;121(6):854-862. doi: 10.1111/bju.14078. Epub 2017 Nov 30. BJU Int. 2018. PMID: 29124889
-
Urinary Incontinence and Sexual Function After the Introduction of NeuroSAFE in Radical Prostatectomy for Prostate Cancer.Eur Urol Focus. 2023 Sep;9(5):824-831. doi: 10.1016/j.euf.2023.03.021. Epub 2023 Apr 7. Eur Urol Focus. 2023. PMID: 37032279
-
NeuroSAFE in radical prostatectomy increases the rate of nerve-sparing surgery without affecting oncological outcome.BJU Int. 2022 Nov;130(5):628-636. doi: 10.1111/bju.15771. Epub 2022 Jun 5. BJU Int. 2022. PMID: 35536200 Free PMC article. Review.
-
Neurovascular Structure-adjacent Frozen-section Examination (NeuroSAFE) During Radical Prostatectomy: A Systematic Review and Meta-analysis.Eur Urol Oncol. 2024 Dec 26:S2588-9311(24)00290-6. doi: 10.1016/j.euo.2024.12.008. Online ahead of print. Eur Urol Oncol. 2024. PMID: 39730246 Review.
Cited by
-
Neurovascular structure-adjacent frozen-section examination vs. standard robot-assisted radical prostatectomy: a systematic review and meta-analysis of two-arm comparative studies on functional and oncological outcomes.J Robot Surg. 2025 Jun 24;19(1):321. doi: 10.1007/s11701-025-02486-z. J Robot Surg. 2025. PMID: 40553352 Review.
-
Patient-Reported Outcome Measures and Decision Regret After Salvage Radical Prostatectomy for Recurrent Prostate Cancer Following Radiotherapy or Focal Therapy.Cancers (Basel). 2025 Jan 25;17(3):396. doi: 10.3390/cancers17030396. Cancers (Basel). 2025. PMID: 39941765 Free PMC article.
-
The impact of prostate volume on Retzius-sparing robot-assisted laparoscopic radical prostatectomy with retrograde release of the neurovascular bundle.BMC Urol. 2025 Mar 27;25(1):59. doi: 10.1186/s12894-025-01745-3. BMC Urol. 2025. PMID: 40148825 Free PMC article.
-
Canadian Urological Association-European Association of Urology 2025 Exchange.Can Urol Assoc J. 2025 Aug;19(8):E290-E293. doi: 10.5489/cuaj.9310. Can Urol Assoc J. 2025. PMID: 40769185 Free PMC article. No abstract available.
References
-
- EAU Guidelines. Edn. presented at the EAU Annual Congress Amsterdam 2022. ISBN 978-94-92671-16-5.
-
- Preston MA, Breau RH, Lantz AG, Morash C, Gerridzen RG, Doucette S, et al. The association between nerve sparing and a positive surgical margin during radical prostatectomy. Urol Oncol Semin Orig Investig. 2015;33:18.e1–18.e6.
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous